Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
AbbVie ( (ABBV) ) has shared an update.
AbbVie announced the retirement of Kevin K. Buckbee from his role as Senior Vice President, Controller, effective March 1, 2025, and the appointment of David R. Purdue to the position. Purdue, who has significant experience within AbbVie and its former parent company, Abbott Laboratories, will assume the role with an annual base salary of $550,000 and will be eligible for performance-based bonuses.
More about AbbVie
AbbVie is a biopharmaceutical company that focuses on developing and marketing advanced therapies for complex and serious diseases.
YTD Price Performance: 15.85%
Average Trading Volume: 5,917,235
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $306.1B
For a thorough assessment of ABBV stock, go to TipRanks’ Stock Analysis page.
